Calcitriol prevents inflammatory gene expression in macrovascular endothelial cells

References

• Lin R, White JH. The pleiotropic actions of vitamin D. BioEssays. 2004;26:21–28.10.1002/(ISSN)1521-1878
   PubMed Web of Science ®Google Scholar
• Jeong MS, Kim JY, Lee HI, et al. Calcitriol may down-regulate mRNA over-expression of toll-like receptor-2 and -4, LL-37 and proinflammatory cytokines in cultured human keratinocytes. Ann. Dermatol. 2014;26:296–302.10.5021/ad.2014.26.3.296
   PubMed Web of Science ®Google Scholar
• Holick MF, Chen TC, Lu Z, et al. Vitamin D and skin physiology: a D-lightful story. Journal of Bone and Mineral Research. 2007;22:V28–V33. doi:10.1359/jbmr.07s211.
   PubMed Web of Science ®Google Scholar
• Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2006;29:722–724. doi:10.2337/diacare.29.03.06.dc05-2148.
   PubMed Web of Science ®Google Scholar
• Andress DL. Vitamin D treatment in chronic kidney disease. Semin Dial. 2005;18:315–321.10.1111/sdi.2005.18.issue-4
   PubMed Web of Science ®Google Scholar
• Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009;120:687–698. doi:10.1161/CIRCULATIONAHA.109.856070.
   PubMed Web of Science ®Google Scholar
• Giulietti A, van Etten E, Overbergh L, et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. Diabetes Res. Clin. Pract. 2007;77:47–57. doi:10.1016/j.diabres.2006.10.007.
   PubMed Web of Science ®Google Scholar
• Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006;86:515–581.10.1152/physrev.00024.2005
   PubMed Web of Science ®Google Scholar
• Rivas-Santiago B, Serrano CJ, Enciso-Moreno JA. Susceptibility to Infectious Diseases Based on Antimicrobial Peptide Production. Infect. Immun. 2009;77:4690–4695.10.1128/IAI.01515-08
   PubMed Web of Science ®Google Scholar
• Guani-Guerra E, Guani-Guerra E, Santos-Mendoza T, et al. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 2010;135:1–11. doi:10.1016/j.clim.2009.12.004.
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr. Opin. Gastroenterol. 2007;23:370–378.10.1097/MOG.0b013e328136c580
   PubMed Web of Science ®Google Scholar
• Barnathan ES, Raghunath PN, Tomaszewski JE, et al. Immunohistochemical localization of defensin in human coronary vessels. Am. J. Pathol. 1997;150:1009–20.
   PubMed Web of Science ®Google Scholar
• Kougias P, Chai H, Lin PH, et al. Neutrophil antimicrobial peptide α-defensin causes endothelial dysfunction in porcine coronary arteries. J. Vasc. Surg. 2006;43:357–363. doi:10.1016/j.jvs.2005.10.019.
   PubMed Web of Science ®Google Scholar
• Edfeldt K, Agerberth B, Rottenberg ME, et al. Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006;26:1551–1557. doi:10.1161/01.ATV.0000223901.08459.57.
   PubMed Web of Science ®Google Scholar
• Quinn KL, Henriques M, Tabuchi A, et al. Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation. Arterioscler. Thromb. Vasc. Biol. 2011;31:2070–2079. doi:10.1161/ATVBAHA.111.227116.
   PubMed Web of Science ®Google Scholar
• Vordenbaumen S, Sander O, Bleck E, et al. Cardiovascular disease and serum defensin levels in systemic lupus erythematosus. Clin. Exp. Rheumatol. 2012;30:364–70.
   PubMed Web of Science ®Google Scholar
• Tello-Montoliu A, Marin F, Patel J, et al. Plasma angiogenin levels in acute coronary syndromes: implications for prognosis. Eur Heart J. 2007;28:3006–3011. doi:10.1093/eurheartj/ehm488.
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Sahiner E, Darcin T, et al. Is vitamin D supplementation a new hope for the therapy of the septic shock? Endocr. Regul. 2013;47:133–136. doi:10.4149/endo_2013_03_133.
   PubMedGoogle Scholar
• Livak kJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• van Ierssel SH, Van Craenenbroeck EM, Hoymans VY, et al. Endothelium dependent vasomotion and in vitro markers of endothelial repair in patients with severe sepsis: an observational study. PLoS One. 2013;8:e69499.10.1371/journal.pone.0069499
   Google Scholar
• Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 2006;36:361–370. doi:10.1002/(ISSN)1521-4141.
   PubMed Web of Science ®Google Scholar
• Thota C, Farmer T, Garfield RE, et al. Vitamin D elicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates toll-like receptors in human myometrial cells. Reprod. Sci. 2013;20:463–475. doi:10.1177/1933719112459225.
   PubMed Web of Science ®Google Scholar
• Li, YC, Chen Y, Liu W, et al. MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. J. Steroid. Biochem. Mol. Biol. 2014;144 Pt A:81–86.
   Google Scholar
• Equils O, Naiki Y, Shapiro AM, et al. 1,25-Dihydroxyvitamin D3 inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin. Exp. Immunol. 2006;143:58–64. doi:10.1111/cei.2006.143.issue-1.
   PubMed Web of Science ®Google Scholar
• Peng Y, Gao M, Jiang Y, et al. Angiogenesis inhibitor endostatin protects mice with sepsis from multiple organ dysfunction syndrome. Shock. 2015;44:357–364. doi:10.1097/SHK.0000000000000427.
   PubMed Web of Science ®Google Scholar
• Goldberg PL, MacNaughton DE, Clements RT, et al. p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 2002;282:L146–54.
   PubMed Web of Science ®Google Scholar
• Hoffmeister HM, Jur M, Ruf-Lehmann M, et al. Endothelial tissue-type plasminogen activator release in coronary heart disease. J. Am. Coll. Cardiol. 1998;31:547–551. doi:10.1016/S0735-1097(97)00531-7.
   PubMed Web of Science ®Google Scholar
• Leaf DE, Raed A, Donnino MW, et al. Randomized controlled trial of calcitriol in severe sepsis. Am. J. Respir. Crit. Care Med. 2014;190:533–541. doi:10.1164/rccm.201405-0988OC.
   PubMed Web of Science ®Google Scholar